Quantamental Technologies’s ResMed RMD Stock Holding History

Quantamental Technologies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,822	Closed	-$835K	–	531
2023 Q2	$835K	Buy	+3,822	New	+$852K	0.35%	78
2023 Q1	–	Sell	-5,900	Closed	-$1.23M	–	587
2022 Q4	$1.23M	Buy	+5,900	New	+$1.3M	0.56%	35
2022 Q2	–	Sell	-3,551	Closed	-$861K	–	538
2022 Q1	$861K	Buy	3,551 +707	+25%	+$171K	0.5%	44
2021 Q4	$741K	Buy	+2,844	New	+$738K	0.38%	81

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantamental Technologies's RMD Position: Q3 2023 in Review

Quantamental Technologies sold out of ResMed (RMD) in Q3 2023, closing a stake of 3,822 shares — an estimated $835K sold.

Quantamental Technologies first reported a position in RMD in Q4 2021 and held it in 4 quarters. The position peaked at $1.23M in Q4 2022. 658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

Quantamental Technologies reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
Quantamental Technologies sold 3,822 ResMed shares in Q3 2023, an estimated $835K.
Quantamental Technologies first reported a position in ResMed in Q4 2021 and held it in 4 quarters.
Quantamental Technologies's ResMed position peaked at $1.23M in Q4 2022.
658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.